-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Invivo Therapeutics Holdings Corp. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2022.
- Invivo Therapeutics Holdings Corp. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $38K, a 2.7% increase year-over-year.
- Invivo Therapeutics Holdings Corp. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $187K, a 3.11% decline year-over-year.
- Invivo Therapeutics Holdings Corp. annual Share-based Payment Arrangement, Expense for 2022 was $159K, a 49.5% decline from 2021.
- Invivo Therapeutics Holdings Corp. annual Share-based Payment Arrangement, Expense for 2021 was $315K, a 46.5% increase from 2020.
- Invivo Therapeutics Holdings Corp. annual Share-based Payment Arrangement, Expense for 2020 was $215K, a 19.8% decline from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)